SRH ADVISORS, LLC

Position in NVO — Novo Nordisk A S

CIK 1512779 SALINA, KS

Position in NVO

as of Jun 30, 2026 · filed Jul 24, 2026 Compact

Position Value

$38,352

+$8,952 QoQ

Shares Held

800

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#1,140

of 1,348 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

SRH ADVISORS, LLC holds $999,326 across 6 Drug Manufacturers - General names. NVO ranks #5 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	267	$320,247
2	JNJ	Johnson & Johnson	1,214	$308,319
3	PFE	Pfizer Inc	9,734	$234,394
4	GILD	Gilead Sciences, Inc.	550	$69,487
5	NVO	Novo Nordisk A S This page	800	$38,352
6	MRK	Merck & Co., Inc.	222	$28,527

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$38,352	800	0.0%	Shares	Sole	2026-07-24
2026-03-31	$29,400	800	0.0%	Shares	Sole	2026-04-29
2025-12-31	$40,704	800	0.0%	Shares	Sole	2026-01-21
2025-09-30	$44,392	800	—	Shares	Sole	2025-10-17
No filing history on record for this holder in this stock.